MarginsXMarginsX
Home › Markets › Industrials › KEQU

Kewaunee Scientific Corporation (KEQU)

KEQU trades on Nasdaq in Industrials, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$35.05
-1.81% on the day
Market cap
$101.5M
Micro cap
Revenue · 2026
$282.0M
+17.3% on 2025
Net income · 2026
$9.6M
3.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-04-30, https://www.sec.gov/Archives/edgar/data/55529/000005552926000020/0000055529-26-000020-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-04-30.

Profile

FieldValue
TickerKEQU on Nasdaq
SectorIndustrials
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000055529
SEC industry codeLaboratory Apparatus & Furniture
Incorporated inDE

Financials · 2026

LineValue
Revenue$282.0M
Net income$9.6M
Operating income$16.7M
Net margin3.4%
Operating margin5.9%
Revenue growth+17.3%
Cash$9.9M
Total assets$178.3M
P/E (computed)10.6×
P/S (computed)0.4×

Warning signs

Cash runway
Cash-flow positive
$8.2M cash at July 31, 2026
Share count, 1 year
+1.0%
2025-09-09 to 2026-09-08 · -0.3% over 3 years
Going-concern doubt
No
10-Q filed September 11, 2026
Insider net buying, 12 months
-$762K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-09-11
Cash and burn$8.2M cash; operating cash flow $3.7M a quarter.Report 2026-07-31
Shares outstanding2,895,347 (2026-09-08); 2,865,694 a year earlier; 2,904,094 three years earlier.Cover page 2026-09-08
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorForvis Mazars, LLP, Raleigh, North Carolina, United StatesPCAOB Form AP 2026-08-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $762K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-07-31
$66.3M$1.7M$2.0M$8.2M$18.8M$277.2M10-Q 2026-09-11
Q4 2026
2026-04-30
$71.4M$3.4M$5.5M$9.9M$20.2M$282.0M10-K 2026-06-26
Q3 2026
2026-01-31
$69.4M$692K$11.6M$8.2M$21.3M$287.7M10-Q 2026-03-13
Q2 2026
2025-10-31
$70.1M$2.4M-$4.3M$12.6M$35.3M$285.5M10-Q 2025-12-12
Q1 2026
2025-07-31
$71.1M$3.1M$5.8M$19.5M$37.4M$263.2M10-Q 2026-09-11
Q4 2025
2025-04-30
$77.1M$4.8M$9.4M$14.9M$38.7M$240.5M10-K 2026-06-26
Q3 2025
2025-01-31
$67.2M$1.4M-$2.3M$9.5M$38.0M$220.0M10-Q 2026-03-13
Q2 2025
2024-10-31
$47.8M$3.0M$8.4M$26.0MNo debt tags$199.6M10-Q 2025-12-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-06-26
Latest quarterly / interim10-Q2026-09-11
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-07-07

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.6%
1 month+10.9%
3 months-2.3%
Year to date-4.6%
1 year-10.9%
From 52-week high-17.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
BDSXBiodesix Inc.$9.00-8.91%$99.8M
XGNExagen Inc.$3.77-8.72%$96.2M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
BNRBurning Rock Biotech Limited$12.74-4.43%$134.4M
TLSITriSalus Life Sciences Inc.$2.27-6.58%$140.1M
YDESYD Bio Limited$4.83-1.02%$342.1M
FLGTFulgent Genetics Inc.$24.07-2.37%$672.6M
MDXHMDxHealth SA$0.1490+3.40%$14.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier